1. Home
  2. III vs ANTX Comparison

III vs ANTX Comparison

Compare III & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Information Services Group Inc.

III

Information Services Group Inc.

HOLD

Current Price

$4.49

Market Cap

203.8M

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$4.65

Market Cap

170.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
III
ANTX
Founded
2006
2017
Country
United States
United States
Employees
1500
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
203.8M
170.6M
IPO Year
2006
2022

Fundamental Metrics

Financial Performance
Metric
III
ANTX
Price
$4.49
$4.65
Analyst Decision
Buy
Buy
Analyst Count
1
1
Target Price
$5.50
$2.00
AVG Volume (30 Days)
231.2K
229.4K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
4.46%
N/A
EPS Growth
216.67
32.56
EPS
0.05
N/A
Revenue
$192,745,000.00
N/A
Revenue This Year
$3.85
N/A
Revenue Next Year
$4.34
N/A
P/E Ratio
$86.50
N/A
Revenue Growth
4.51
N/A
52 Week Low
$3.74
$1.00
52 Week High
$6.45
$6.91

Technical Indicators

Market Signals
Indicator
III
ANTX
Relative Strength Index (RSI) 62.21 55.19
Support Level $4.44 $1.06
Resistance Level $6.06 $5.09
Average True Range (ATR) 0.18 0.44
MACD 0.03 -0.03
Stochastic Oscillator 90.69 52.90

Price Performance

Historical Comparison
III
ANTX

About III Information Services Group Inc.

Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: